Numerous studies have indicated that in cancer treatment Chinese herbal medicines in
combination with chemo-, radio-, or targeted-therapy can be used to enhance the efficacy of …

This meta analysis evaluated the comparative safety and efficacy for the addition of
Astragalus-based Chinese medicines combined with chemotherapy and chemotherapy …

Colorectal cancer (CRC) is regarded as one of the commonest cancer types around the
world. Due to the poor understanding on the causes of CRC formation and progression, this …

Following a cancer diagnosis, dietary supplements are reportedly used by 20%–80% of
individuals. Supplements are most commonly used by breast cancer survivors, followed by …

Introduction: The incidence and mortality of gastric cancer ranks among the highest, and the
5-year survival rate of advanced gastric cancer (AGC) is less than 10%. Currently …

Purpose: The purpose of this study was to determine if an Astragalus polysaccharide (RAP)
can protect immune cells from the toxic side effects of paclitaxel (Taxol), a powerful anti …

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and
severe adverse effects related to cancer treatment. Unfortunately, although several agents …

Background Radix Tetrastigma hemsleyani flavone (RTHF) is extracted from a traditional
Chinese medicinal herb T. hemsleyani, which is conventionally used as a folk medicine for …

Astragalus membranaceus and Curcuma zedoaria, two traditional Chinese medicines, are
widely used together in colorectal cancer adjuvant treatment. Many different mechanisms …

Background Despite granulocyte colony-stimulating factor (GCSF) is widely used in clinical,
cancer chemotherapy induced neutropenia (CCIN) infection and infection-related mortality is …